Schweizerische Gesellschaft für Kardiologie
Société Suisse de Cardiologie
Società Svizzera di Cardiologia
Kontakt

Assemblée Annuelle commune 2017:
Société Suisse de Cardiologie (SSC) et Société Suisse de Chirurgie Cardiaque et Vasculaire Thoracique (SSCC)

7 au 9 juin 2017, Trafo Baden

 

 

 


 

 

Programme de jeudi, 12.06.2014

Temps Sujet Modération Lieu
06:30-07:00 Running/Walking Interlaken
M. Gsponer (Kilchberg, CH)
   
07:15-08:00 Satellite symposium Kursaal, Brünig
Amgen Switzerland AG Amgen Switzerland AG
  “Meet the Expert – Breakfast” – Innovation is the Future: Fighting "Bad" Cholesterol
Vorsitz/Modération:  U. Landmesser, (Zürich, CH)
 
Novel targeted therapies in lipid management - The PCSK9 Area
K. Parhofer (München, DE)
Monoclonal antibodies and their potential in CVD treatment
D. Neri (Zürich, CH)
   
08:00-09:00 Satellite symposium Kursaal, Ballsaal
Sanofi- Aventis (Schweiz) AG Sanofi- Aventis (Schweiz) AG
  Novel Therapeutic Approach for the Management of Hypercholesterolemia
Vorsitz/ Modération: J-H. Beer (Baden, CH)
 
Management of Hypercholesterolemia: Where do the challenges lie?
U. Landmesser (Zürich, CH)
PCSK-9 Inhibition: Mechanism of Action
St. Krähenbühl (Basel, CH)
Alirocumab: Study Results and Development Program
F. Mach (Genève, CH)
   
08:00-09:00 Satellite symposium Kursaal, Club Casino
Biosense Webster Biosense Webster
  Approaches in VT ablation and predictors of success
Vorsitz/ Modération: A. D'Avila (New York, US)
  A. Arenal (Madrid, SP)  
   
08:00-09:00 Oral Session 4 Kursaal, Harder 1- 2
  Imaging and congenital "methodological aspects"
Vorsitz/ Modération: A. Wahl  (Bern, CH)
S. De Marchi (Bern, CH)
 
Contrast echocardiography for screening of pulmonary arterio-venous fistula in children with portal hypertension
C. Tissot (Genève, CH)
Cardiac magnetic resonance based management of coronary artery disease at 3.0 Tesla: Insights from a large single center experience
St. Muzzarelli (Lugano, CH)
Evaluation of chronic mitral regurgitation by 3-D color doppler echocardiography vs cardiac magnetic resonance imaging as the reference method
N. Brugger (Bern, CH)
A novel compressed sensing multi-slice cmr approach for the assessment of left ventricular volumes and function in one breath-hold
G. Vincenti (Lausanne, CH)
   
08:00-09:00 Oral Session 5 Kursaal, Rugen
  Blood pressure and heart function
Vorsitz/ Modération: W. Deuel (St. Gallen, CH)
St. Rimoldi (Bern, CH)
 
Renal denervation leads to reduction of blood pressure without orthostatic hypotension in a coohort of swiss patients with treatment-resistant hypertension
I. Sudano (Zürich, CH)
A standardized treatment approach combined with medication adherence monitoring normalizes blood pressure in 53% of 17 refractory hypertensives
G. Ehret (Genève, CH)
Arterial hypertension and cardiac remodeling in middle-aged endurance athletes
M. Wilhelm (Bern, CH)
Ecg P-wave duration increases with age and lean body mass but not with components of the metabolic syndrome in the general population
P. Monney (Lausanne, CH)
   
09:15-10:45 Main Session 3 Kursaal, Ballsaal
  Changing diagnostics
Vorsitz/ Modération: M.Togni (Fribourg, CH)
W.Maier (Zürich, CH)
 
The role of the ECG in ACS
Ch. Wyss (Zürich, CH)
New and old cardiac biomarkers
P. Ammann (St.Gallen, CH)
Impact of FFR and iFR on current PCI strategies
O. Muller (Lausanne, CH)
Non cardiac chest pain?
R. Tutuian (Bern, CH)
   
09:15-10:45 Workshop 6 Kursaal, Club Casino
  Interaction gastroenterology-cardiology
Vorsitz/ Modération: R. Jost (Winterthur, CH)
M. Zuber (Luzern, CH)
 
Gastroenterological contraindications for TEE
D. Criblez (Luzern,CH)
Gastroenterological complications after cardiac interventions
Ch. Gubler (Zürich, CH)
Left atrial ablation - good for the heart, risky for the gullet
L. Roten (Bern, CH)
Postoperative intestinal ischemia
A. Künzli (Kreuzlingen, CH)
   
09:15-10:45 Scientific Session 2 Kursaal, Brünig
  Palliative care: A challenge for inter-professional care teams
Vorsitz/ Modération: N. Zigan (Winterthur, CH)
L. Weibel (Basel, CH)
 
Palliative care in cardiology: Benefit for whom, what kind, and when?
St. Eychmüller (Bern, CH)
End-of-life care in hospitalized adults with complex congenital heart disease: 
Care delayed, care denied
D. Stambach (St. Gallen, CH)
Symptom management in specialized palliative care: Who is responsible for what?
H.Rettke (Zürich, CH)
Pflege von Patienten zuhause – Langzeitaspekte
V. Waldboth (Winterthur, CH); R.M. Wjinands (Zürich, CH)
   
09:15-10:45 Oral Session 6 Kursaal, Harder 1-2
  Mechanisms of cardiovascular disease
Vorsitz/ Modération: N. Rosenblatt-Velin (Lausanne, CH)
Z. Yang (Fribourg, CH)
 
Anti-apolipoprotein A1 autoantibodies induce tissue factor activity and expression: A Role In Atherothrombosis
S. Pagano (Genève, CH)
The adaptor protein P66shc mediates hypertension associated, cyclic stretch-dependent, endothelial damage
R. Spescha (Schlieren, CH)
Increased GLP-1 levels restore vascular and endothelial protective HDL functions after RYGB
E. Osto (Schlieren, CH)
Titrating connexin43 in immune cells decreases atherosclerotic plaque development in mice
S. Morel (Genève, CH)
Sphingosine-1-Phosphate cardioprotection against ischemia/reperfusion injury
S. Morel (Genève, CH)
Endothelial lox-1 protects against arterial thrombosis via activation of the OCT-1/SIRT1 pathway
A. Akhmedov (Schlieren, CH)
   
09:15-10:45 Oral Session 7 Kursaal, Rugen
  Mechanisms and therapy of cardiac arrhythmias
Vorsitz/ Modération: R. Kobza (Luzern, CH)
D. Altmann (St. Gallen, CH)
 
Benign versus malignant inferolateral early repolarization: The T wave makes the difference
L. Roten (Bern, CH)
Concomitant atrial fibrillation ablation and left atrial appendage occlusion
S. Baldinger (Bern, CH)
Improved outcome following cardiac resynchronization therapy is related to higher doses of ace inhibitors, angiotensin receptor antagonists and beta blockers and lower doses of diuretics
S. Schmidt (Uster, CH)
Intrathoracic pressure swings promote heart rhythm disturbances in patients with paroxysmal atrial fibrillation.
Ch. Schlatzer (Zürich, CH)
The crucial role of interlesion distance in addition to catheter-tissue contact force to ensure durable pulmonary vein isolation in patients undergoing radiofrequency ablation for atrial fibrillation
Ch.-I. Park (Bad Krozingen, DE)
Usefulness of electrocardiographic abnormalities for risk prediction in arrhythmogenic right ventricular cardiomyopathy
A. Saguner (Zürich, CH)
   
11:00-12:30 Workshop 7 Kursaal, Ballsaal
  Contemporary management of ventricular arrhythmia
Vorsitz/ Modération: A. Menafoglio (Lugano, CH)
S. Reek (Aarau, CH)
 
Ventricular tachycardia: What does the 12-lead ECG tell us?
M. Zimmermann (Genève, CH)
Ventricular arrhythmia in post-MI patients and an LVEF >35%
E. Pruvot (Lausanne, CH)
ICD indication 2014 - A critical appraisal
B. Schär (Basel, CH)
VT-ablation in post-MI patients
J. Seiler (Bern, CH)
   
11:00-12:30 Workshop 8 Kursaal, Club Casino
  Problems in cardiac imaging
Vorsitz/ Modération: X. Jeanrennaud (Lausanne, CH)
F. Tanner (Zürich, CH)
 
Low flow, low gradient aortic stenosis
P. Monney (Lausanne, CH)
How to judge mitral incompetence
A. Delabays (Lausanne, CH)
How to assess ischemia after myocardial infarction
St. Muzzarelli (Lugano, CH)
What is the utility of myocardial strain in 2014?
Ch. Gruner (Zürich, CH)
What does the surgeon need?
O. Reuthebuch (Basel, CH)
   
11:00-12:30 Scientific Session 3 Kursaal, Brünig
  Prevention from different points of view
Vorsitz/ Modération: H. Geschwindner (Zürich, CH)
M. Schärli-Purtschert (Zürich, CH)
 
Building up a transition program for young people with congenital heart disease: What works?
E.-L. Bratt (Göteborg, SE)
Primär-, Sekundär- und Tertiärprävention: Wer braucht was in der Gesundheitsförderung?
R. Mahrer Imhof (Winterthur, CH)
Rauchstopp
I. Sudano (Zürich, CH) 
Rauchstopp inkl. Aktueller Literatur
B. Kubli (Zürich, CH)
Prävention aus Sicht der Ernährungsberatung: Wirksame Methoden zur Präventionsförderung
Ch. Germi (Barmelweid, CH)
   
11:00-12:30 Workshop 9 Kursaal, Harder 1-2
  The role of diet for cardiovascular diseases
Vorsitz/ Modération: W. Riesen (Diessenhofen, CH)
R. Mordasini (Bern, CH)
 
Mediterranean diet
G. Noseda (Mendrisio, CH)
Fish and omega 3-fatty acids
J. Beer (Baden, CH)
Red meat
S. Rohrmann (Zürich, CH)
Alcohol
D. Conen (Basel, CH)
Nutraceuticals
P. Suter (Zürich, CH)
FODMAP
M.Fried (Zürich, CH)
   
11:00-12:30 Oral Session 8 Kursaal, Rugen
  Antithrombotic therapy and coronary revascularization
Vorsitz/ Modération: Ch. Röthlisberger (Biel. CH)
D. Sürder (Lugano, CH)
 
Short versus standard 12-month dual antiplatelet therapy duration after arug-eluting stent implantation
G. Stefanini (Bern, CH)
Frequency and predictors of gastrointestinal bleeding in unselected patients undergoing percutaneous coronary intervention
L. Räber (Bern, CH)
Safety and efficacy of concurrent administration of clopidogrel and prasugrel loading doses among patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
L. Räber (Bern, CH)
Use and impact of prasugrel in patients with acute coronary syndrome in Switzerland. 
Results from the amis plus registry
D. Kurz (Zürich, CH)
Impact on clinical outcome of high/low on-clopidogrel platelet reactivity according to concordant platelet function tests
C. Pellaton (Yverdon, CH)
Prasugrel increases bleeding complications and surgical re-exploration rates compared with clopidogrel in coronary artery bypass surgery
S. Drews (Basel, CH)
     
11:00-13:00 AMIS Plus Steering Committee Meeting Kursaal, Grimsel
   
12:30-13:00 Kaffeepause in der Piazza und Industrieausstellung
Pause café dans la piazza et l`exposition
     
12:45-13:45 Generalversammlung AG KAP Kursaal, Brünig
Assemblée générale  
Vorsitz/ Modération: G. Stoffel (Zürich, CH)
   
13:00-14:00 Satellite symposium Kursaal, Ballsaal
Novartis Pharma Schweiz AG
  Symposium satellite
  Novartis Pharma Schweiz AG
  Paradigm shift in Acute Heart Failure Management
Vorsitz/ Modération:  F. Mach (Genève, CH)
 
Embarking on a downward journey – what are the mechanisms responsible for acute decompensation in patients with HF?
R. Hullin (Lausanne, CH)
Where does the downward journey take us? The pathophysiological consequences of AHF on end organs
Ch. Müller (Basel, CH)
Beyond current treatment strategies: Can new approaches help us to move upward?
Th. Suter (Bern, CH)
Summary and close
F. Mach (Genève, CH)
     
13:00-14:00 Symposium satellite Kursaal, Club Casino
Bristol-Myers Squibb SA / Pfizer AG Bristol-Myers Squibb SA / Pfizer AG
  Überblick über die NOACs
Vorsitz/ Modération:  St. Windecker (Bern, CH)
 
NOACs im klinischen Alltag – ein Vergleich
N. Kucher (Bern, CH)
Praxisrelevante Aspekte von Eliquis – Falldiskussionen
J. Steffel (Zürich, CH)
     
13:00-14:00 Posterbegehung Poster Areas 1-3
Session de présentation des posters
   
14:00-15:30 Workshop 10 Kursaal, Brünig
  Best practices and realities
Vorsitz/ Modération: S. Bischoff (Bern, CH)
E. Burtscher (Chur, CH)
 
Postoperative care of cardiologic patients - A nurse’s challenge
E. Horvath (Zürich, CH) / S. Pessach-Bamert (Zürich, CH)
Hospitalized heart patients - Is delirium manageable?
M. Leventhal (Pfeffingen, CH)
Der Übergang von der stationären zur ambulanten Pflege: Wie können wir die Lücke schliessen?
C. Bläuer (Basel, CH)
Challenges for parents caring for children with complex congenital heart disease at home
G. Stoffel (Zürich, CH)
Geeignete Messinstrumente in der Rehabilitationspflege: Erweiterter Barthel Index (EBI) vs Ergebnisorientiertes Pflegeassessment (ePA_AC)
S. Suter-Riederer (Winterthur, CH)
   
14:15-15:15 Satellite symposium Kursaal, Ballsaal
Astra Zeneca AG Astra Zeneca AG
  Ticagrelor’s dual mode of action – From acute care to survival benefit in ACS
 
Ticagrelor under a new light: A dual mode of action unveiled
J.-H. Beer (Baden)
STEMI - Time is Muscle: Latest data from the AMIRAL Registry
J.- F. Iglesias (Lausanne)
Ticagrelor - The journey goes on
St. Windecker (Bern)
   
14:15-15:15 Satellite symposium Kursaal, Club Casino
Bayer (Schweiz) AG Bayer (Schweiz) AG
  Das Duell – Antikoagulation mit NOACs vs. VKA  
Vorsitz/ Modération: Prof. B. Meier (Bern, CH)
  Prof S. Osswald (Basel, CH)  
   
„Pro-VKA bzw. die „Aera prä NOAC“  
Dr. D. Evéquoz (Brig, CH)  
„Pro-NOAC bzw. die „Aera post VKA“  
Prof. B. Meier (Bern, CH)  
   
14:15-15:15 Workshop 11 Kursaal, Harder 1-2
  Young Swiss Cardiac Surgeons Club Meeting
Vorsitz/ Modération:  D. Reser (Zürich, CH)
D. Reineke (Bern, CH)
 
Modular training for cardiac surgery in Germany
A.-L. Poetini (Mainz, DE)
Cardiac surgical skills and training today and yesterday: two truths cannot be contradictory
M. Genoni (Zürich, CH)
Achievements of the YSCSC
D. Reser (Zürich, CH)
     
14:15-15:15 Tariff commission meeting Kursaal, Rugen
   
15:30-17:00 Main Session 4 Kursaal, Ballsaal
  Guidelines ESC: Diabetes, hypertension, stable CAD, preoperative assessment

Panel: S. Osswald (Basel, CH)
F. Muggli (Lugano, CH)
H. Rickli (St.Gallen, CH)
G. Noll (Zürich, CH)
F. Siclari (Lugano, CH)
 
ESC Guidelines: "Management of arterial hypertension"
G. Würzner (Lausanne, CH)
ESC Guidelines: "Management of stable coronary artery disease"
M. Zellweger (Basel, CH)
ESC Guidelines: "Diabetes, pre-diabetes and cardiovascular diseases developed with the EASD"
M. Roffi (Genève, CH)
   
15:30-17:30 Workshop 12 Kursaal, Club Casino

Complex coronary artery interventions: State of the art 2014
Vorsitz/ Modération: V. Falk (Zürich, CH)
St. Windecker (Bern, CH)
 
Left main-intervention
M. Roffi (Genève, CH)
Small vessel interventions: New concepts for underestimated arteries
R. Jeger (Basel, CH)
Management of large thrombus burden: Patience is the way to success
F. Cuculi (Luzern, CH)
Bifurcation lesions
F. Eberli (Zürich, CH)
The why and how of CTO-interventions
D. Weilenmann (St. Gallen, CH)
New directions in stent-techniques
Ch. Roguelov (Lausanne, CH)
Why not ask the surgeon?
O. Dzemali (Zürich, CH)
   
15:30-17:00 Workshop 13 Kursaal, Brünig
  Practice projects in patient education
Vorsitz/ Modération: K. Vogt (Barmelweid, CH)
V. Cattilaz (St. Gallen, CH)
 
Interprofessionelles Edukationsprogramm für stationäre Patienten mit 
Herzinsuffizienz am Kantonsspital St. Gallen
M. Müller (St. Gallen, CH)
Förderung der Sekundärprävention bei Patientinnen und Patienten mit koronarer 
Herzkrankheit durch motivierende Gesprächsführung
M. Bonhôte Börner (Bern, CH)
Herzkompass 2.0: Ein E-Health Tool für die pädiatrische Kardiologie
M. Thomi (Basel, CH)
Wiederintegration zu Hause ermöglichen
C. Gabriel (Luzern, CH)
   
15:30-17:00 Workshop 14 Kursaal, Harder 1-2
  The intestine as a target for prevention and treatment of atherosclerosis
Vorsitz/ Modération: G. Kullak-Ublick (Zürich, CH)
F.Mach (Genève, CH)
 
Handling of lipids and lipoproteins by the intestine: Lessons from inborn errors of metabolism, animal models and interventions
R. James (Genève, CH)
Intestinal hormones: Lessons from bariatric surgery
Th. Lutz (Zürich, CH)
The far reach of gut bacteria: metabolites and translocations affecting the heart
H. Brüssow (Lausanne, CH)
Cardiovascular risk factors and the GI tract
R. Jost (Winterthur, CH)
   
15:30-17:00 Oral Session 9 Kursaal, Rugen
  Transcatheter aortic valve implantation
Vorsitz/ Modération:  F. Maisano (Zürich, CH)
P. Huser (tbd)
 
Is a short cut better? Transapical versus transfemoral transcatheter aortic valve implantation
R. Trunfio (Lugano, CH)
Validation of the valve academic research consortium definition of bleeding among patients undergoing transcatheter aortic valve implantation
St. Stortecky (Bern, CH)
Localization and natural course of paravalvular regurgitation after implantation of the self-expanding corevalve: Insights from serial tee measurements
B. van Schie (Zürich, CH)
Prothesis-specific predictors of paravalvular regurgitation after transcatheter aortic valve implantation: Impact of calcification and sizing on balloon-expandable versus self-expandable transcatheter heart valves
B. Stähli (Zürich, CH)
Long-term clinical outcome of high-risk patients with severe aortic stenosis according to treatment modality: Tavi Vs. Savr Vs. medical treatment
St. Stortecky (Bern, CH)
Transcatheter aortic valve implantation in Switzerland: Early peri-procedural and 30 day outcomes from the national, multicenter Swiss Tavi registry
St. Stortecky (Bern, CH)
 
17:15-18:15 Satellite symposium Kursaal, Ballsaal
Daiichi Sankyo (Schweiz) AG Daiichi Sankyo (Schweiz) AG
Anticoagulation 2014: Where are we going?
Vorsitz/ Modération:  H. Rickli (St. Gallen, CH)
 
Laboratory results and their proper clinical implementations
W. Korte (tbd)
A new option in the treatment of patients with atrial fibrillation
M. Kühne (Basel, CH)
Anticoagulation with NOACs - a comparison of current treatment options
J. Steffel (Zürich, CH)
     
17:15-18:15 Swiss Society of Cardiology Quiz Kursaal, Brünig
Daiichi Sankyo (Schweiz) AG Vorsitz/ Modération:  F. Messerli (New York. US)
   
17:15-18:15 Workshop 15 Kursaal, Harder 1-2
  ECG-Quiz
Vorsitz/ Modération: A. Menafoglio (Lugano, CH)
Redner/ Orateurs: E. Pruvot (Lausanne, CH)
J. Seiler (Bern, CH)
Th. Wolber (Zürich, CH)
M. Di Valentino (Lugano, CH)
   
17:15-18:15 Oral Session 10 Kursaal, Rugen
  Coronary heart disease risk factors
Vorsitz/ Modération: W. Kottmann (Seewis, CH)
M. Vona (Billens, CH)
 
Histopathological characterization of thrombi harvested from occluded coronary during primary percutaneous coronary intervention - TOC trial
M.N. Giraud (Bellinzona, CH)
Cardiovascular screening in middle-aged individuals engaged in high intensity sport activities: implications, yield and cost-analysis
M. Di Valentino (Belinzona, CH)
The association between resistin concentrations and the occurrence of cardiovascular disease in older persons: The health, aging and body composition (Health ABS) Study
B. Gencer (Genève, CH)
Plasma endothelin-1 and cardiovascular risk among young and healthy adults
M. Bossard (Basel, CH)
     
19:00-20:30 Publikumsveranstaltung Schweizerische Herzstiftung Kursaal, Ballsaal
   
19:30-24:00  Dîner convivial